Physical activity pattern and migraine according to aura symptoms in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) cohort: A cross-sectional study

Imagem de Miniatura
Arquivos
art_OLIVEIRA_Physical_activity_pattern_and_migraine_according_to_aura_2022.PDF (434.73 KB)
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
MOLINA, Maria del Carmen B.
Citação
HEADACHE, v.62, n.8, p.977-988, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective To estimate the associations of physical activity (PA) levels with migraine subtypes. Background Physical activity has been associated with reduced migraine prevalence, but less is known about its relationship with migraine subtypes and PA levels as recommended by World Health Organization (WHO). Methods In this cross-sectional analysis of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), we estimated the odds ratios (ORs) of migraine with aura (MA) and migraine without aura (MO), compared to participants without headaches, according to PA levels in the leisure time (LTPA), commuting time (CPA), and combined PA domains. Results In total, 2773 participants provided complete data, 1556/2773 (56.1%) were women, mean (SD) age of 52.3 (9.1) years. In this study's sample, 1370/2773 (49.4%) participants had overall migraine, 480/2773 (17.3%) had MA, and 890/2773 (32.0%) had MO. In the LTPA domain, there were reduced odds of MA (OR 0.72, 95% confidence interval [CI] 0.53-0.96; p = 0.030) and MO (OR 0.71, 95% CI 0.56-0.90; p = 0.005) in participants who met the WHO PA guidelines after adjustment for confounder variables. In the analyses stratified by intensity, moderate LTPA was associated with reduced odds of MA (OR 0.56, 95% CI 0.320-0.99; p = 0.049), while vigorous LTPA was associated with reduced odds of MO (OR 0.55, 95% CI 0.395-0.77; p = 0.001). There were no significant associations between migraine subtypes and CPA or combined PA domains. In the whole migraine sample, meeting the WHO PA guidelines in the LTPA (OR 0.275, 95% CI 0.083-0.90; p = 0.034), CPA (OR 0.194, 95% CI 0.064-0.58; p = 0.004), and combined domains (OR 0.115, 95% CI 0.032-0.41; p = 0.001) was associated with reduced odds of daily migraine attack frequency. Conclusions Meeting the WHO PA guidelines for LTPA, but not CPA or combined PA domains, is associated with lower migraine occurrence. Moderate LTPA favors MA reduction, while vigorous LTPA favors MO reduction.
Palavras-chave
exercise therapy, migraine, migraine with aura, physical activity
URI
https://observatorio.fm.usp.br/handle/OPI/49077
Referências
  1. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  2. BARBIROLI B, 1992, NEUROLOGY, V42, P1209, DOI 10.1212/WNL.42.6.1209
  3. Benedetti Tânia R. Bertoldo, 2007, Rev Bras Med Esporte, V13, P11, DOI 10.1590/S1517-86922007000100004
  4. Bensenor IJM, 1997, ARQ NEURO-PSIQUIAT, V55, P364, DOI 10.1590/S0004-282X1997000300003
  5. Celis-Morales Carlos A, 2017, BMJ, V357, pj1456, DOI 10.1136/bmj.j1456
  6. Cleland C, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0642-3
  7. Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
  8. Dinu M, 2019, SPORTS MED, V49, P437, DOI 10.1007/s40279-018-1023-0
  9. Farris SG, 2018, CEPHALALGIA, V38, P1707, DOI 10.1177/0333102417747231
  10. Granata C, 2018, SPORTS MED, V48, P1541, DOI 10.1007/s40279-018-0894-4
  11. Greenwood BN, 2008, NEUROMOL MED, V10, P81, DOI 10.1007/s12017-008-8029-y
  12. Griep RH, 2016, AM J IND MED, V59, P987, DOI 10.1002/ajim.22620
  13. Gross EC, 2019, NAT REV NEUROL, V15, P627, DOI 10.1038/s41582-019-0255-4
  14. Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6
  15. Hagen K, 2018, CEPHALALGIA, V38, P1919, DOI 10.1177/0333102418764888
  16. Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898
  17. Hammond NG, 2019, HEADACHE, V59, P1547, DOI 10.1111/head.13610
  18. Hanssen H, 2018, SCAND J MED SCI SPOR, V28, P1103, DOI 10.1111/sms.13023
  19. Hanssen H, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01086
  20. Hauge AW, 2011, CEPHALALGIA, V31, P416, DOI 10.1177/0333102410382795
  21. Hougaard A, 2013, NEUROLOGY, V80, P428, DOI 10.1212/WNL.0b013e31827f0f10
  22. Ide PH, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00142919, 10.1590/0102-311x00142919]
  23. Instituto Brasileiro de Geografia e Estat?stica, 2013, PESQUISA NACL AMOSTR, V39
  24. Kilpatrick MW, 2014, ACSMS HEALTH FIT J, V18, P11
  25. Kumar P, 2019, NEUROIMAG CLIN N AM, V29, P261, DOI 10.1016/j.nic.2019.01.006
  26. Le H, 2011, J HEADACHE PAIN, V12, P157, DOI 10.1007/s10194-011-0321-9
  27. Lee H, 2018, ENVIRON INT, V121, P383, DOI 10.1016/j.envint.2018.09.022
  28. Li WY, 2019, ENVIRON INT, V132, DOI 10.1016/j.envint.2019.105100
  29. Molarius A, 2008, HEADACHE, V48, P1426, DOI 10.1111/j.1526-4610.2008.01178.x
  30. Nunes MA, 2011, REV HCPA, V31, P487
  31. Oliveira AB., 2021, CEPHALALGIA, V19, P1467
  32. Oliveira AB, 2019, CANNABIS CANNABINOID, V4, P275, DOI 10.1089/can.2018.0057
  33. Oliveira AB, 2017, NEUROIMMUNOMODULAT, V24, P293, DOI 10.1159/000487141
  34. Oliveira AB, 2017, J NEUROIMMUNOL, V313, P138, DOI 10.1016/j.jneuroim.2017.09.008
  35. Queiroz LP, 2009, CEPHALALGIA, V29, P642, DOI 10.1111/j.1468-2982.2008.01782.x
  36. SACQUEGNA T, 1992, ACTA NEUROL SCAND, V86, P376, DOI 10.1111/j.1600-0404.1992.tb05104.x
  37. Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20
  38. Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x
  39. Snijder RJR, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003771
  40. Targino AC, 2018, ENVIRON POLLUT, V242, P539, DOI 10.1016/j.envpol.2018.07.003
  41. Tarp J, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00945-4
  42. Treff C, 2017, J HUM HYPERTENS, V31, P278, DOI 10.1038/jhh.2016.75
  43. UNCINI A, 1995, J NEUROL SCI, V129, P214, DOI 10.1016/0022-510X(94)00283-T
  44. Varkey E, 2008, CEPHALALGIA, V28, P1292, DOI 10.1111/j.1468-2982.2008.01678.x
  45. World Health Organization, 2020, WHO GUID PHYS ACT SE, P104

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - HU
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - LIM/21
Artigos e Materiais de Revistas Científicas - LIM/51